Aprotinin in cardiac surgery - re-evaluation of the risks?

被引：0
作者：
Vanek, T. [1 ]
Hlavicka, J. [1 ]
Budera, P. [1 ]
机构：
[1] Kardiochirurg Klin 3 LF UK, Srobarova 50, Prague 10034 10, Czech Republic
来源：
ANESTEZIOLOGIE A INTENZIVNI MEDICINA | 2016年 / 27卷 / 05期
关键词：
cardiac surgery; fibrinolysis; fibrinolytic inhibitors; aprotinin;
D O I：
暂无
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
The article describes the history of introducing aprotinin into cardio-surgical clinical practice and deals with the circumstances based on the results of the BART study leading to its withdrawal from the global pharmaceutical market and with its recent re-authorization in some countries.
引用
收藏
页码：284 / 288
页数：5
相关论文
共 50 条
  • [1] Benefits and risks of aprotinin use during cardiac surgery
    Kristeller, Judith L.
    Roslund, Brian P.
    Stahl, Russell F.
    PHARMACOTHERAPY, 2008, 28 (01): : 112 - 124
  • [2] Aprotinin in cardiac surgery
    Bremerich, D. H.
    Strametz, R.
    Kirchner, R.
    Moritz, A.
    Zwissler, B.
    ANAESTHESIST, 2006, 55 (09): : 989 - 996
  • [3] Should aprotinin continue to be used during cardiac surgery?
    Levy, JH
    Despotis, GJ
    Spitznagel, E
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2006, 3 (07): : 360 - 361
  • [4] Brain natriuretic peptide in cardiac surgery - Influence of aprotinin
    Bail, Dorothee H. L.
    Ziemer, Gerhard
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 136 (02) : 227 - 228
  • [5] Is There Still a Role for Aprotinin in Cardiac Surgery?
    Neel R. Sodha
    Munir Boodhwani
    Frank W. Sellke
    Drug Safety, 2007, 30 : 731 - 740
  • [6] Aprotinin and perioperative complications in cardiac surgery
    Kertai, M. D.
    Varga, K. S.
    Royston, D.
    London, M. J.
    Szabolcs, Z.
    Grebenik, C. R.
    Acsady, G.
    Gal, J.
    JOURNAL OF CARDIOVASCULAR SURGERY, 2007, 48 (06) : 761 - 772
  • [7] Retrospective analysis of benefit/risk ratio of aprotinin in cardiac surgery
    Chu, Celine
    Moreau, Emilie
    Chauffert, Maryline
    Bezie, Yvonnick
    Fromes, Yves
    PHARMACY WORLD & SCIENCE, 2009, 31 (01): : 129 - 130
  • [8] Con: Aprotinin should not be used in cardiac surgery with cardiopulmonary bypass
    Augoustides, John G. T.
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2007, 21 (02) : 302 - 304
  • [9] Aprotinin in cardiac surgery patients: is the risk worth the benefit? comment
    Carrel, Thierry
    Englberger, Lars
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2009, 36 (05) : 875 - 876
  • [10] IS THERE A PHASE OF HYPERCOAGULABILITY WHEN APROTININ IS USED IN CARDIAC-SURGERY
    FEINDT, P
    SEYFERT, U
    VOLKMER, I
    HUWER, H
    KALWEIT, G
    GAMS, E
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1994, 8 (06) : 308 - 313
12345